Your browser doesn't support javascript.
loading
Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer.
Wang, Xing; Yu, Jiandi; Wen, Huali; Yan, Junfeng; Peng, Kun; Zhou, Haiyong.
Afiliación
  • Wang X; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China.
  • Yu J; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China.
  • Wen H; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China.
  • Yan J; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China.
  • Peng K; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China.
  • Zhou H; Department of Urology, Zhejiang Hospital, # 1229, Gudun Road, Hangzhou, 310030, China. zhy821101@163.com.
BMC Urol ; 23(1): 148, 2023 Sep 19.
Article en En | MEDLINE | ID: mdl-37726767

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article